The Current Ratio as of December 2025 (TTM) for Vicore Pharma Holding AB (publ) (VICO.ST) is 13.86

According to Vicore Pharma Holding AB (publ)’s latest financial reports and current stock price. The company's current Current Ratio is 13.86. This represents a change of -11.24% compared to the average of 15.62 of the last 4 quarters.

Vicore Pharma Holding AB (publ) (VICO.ST) Historical Current Ratio (quarterly & annually)

How has VICO.ST Current Ratio performed in the past?

The mean historical Current Ratio of Vicore Pharma Holding AB (publ) over the last ten years is 9.05. The current 13.86 Current Ratio has changed 15.21% with respect to the historical average. Over the past ten years (40 quarters), VICO.ST's Current Ratio was at its highest in in the June 2017 quarter at 23.88. The Current Ratio was at its lowest in in the June 2018 quarter at 1.00.

Vicore Pharma Holding AB (publ) (VICO.ST) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Vicore Pharma Holding AB (publ) Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Vicore Pharma Holding AB (publ) (VICO.ST) Average Current Ratio

How has VICO.ST Current Ratio performed in the past?

The current Current Ratio of Vicore Pharma Holding AB (publ) (VICO.ST) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Vicore Pharma Holding AB (publ) (VICO.ST) Current Ratio vs. Peers

How is VICO.ST’s Current Ratio compared to its peers?

Vicore Pharma Holding AB (publ)’s Current Ratio is greater than Hansa Biopharma AB (publ) (1.11), greater than Egetis Therapeutics AB (publ) (0.80), greater than BioInvent International AB (publ) (7.40), greater than Saniona AB (publ) (5.34), greater than Diamyd Medical AB (publ) (10.64), greater than Oncopeptides AB (publ) (3.42), greater than Humana AB (publ) (0.69), greater than Cantargia AB (publ) (5.82), greater than SynAct Pharma AB (3.28), greater than Xspray Pharma AB (publ) (6.72),

Build a custom stock screener for Vicore Pharma Holding AB (publ) (VICO.ST) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Vicore Pharma Holding AB (publ) using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Vicore Pharma Holding AB (publ) (VICO.ST) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Vicore Pharma Holding AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.